CONSENT OF SMITH ANGLIN & CO.
Published on January 26, 2000
EXHIBIT 23(d)
Consent of Independent Auditors
The Board of Directors
ACCESS Pharmaceuticals, Inc.
We consent to the use of our report on the 1994 consolidated financial
statements of ACCESS Pharmaceuticals, Inc. (a development stage
enterprise) included herein and to the reference to our Firm under the
heading "Experts" in the prospectus.
/s/ Smith Anglin & Co.
- ----------------------
Smith Anglin & Co.
Dallas, Texas
January 24, 2000